Alerts will be sent to your verified email
Verify Email
GUFICBIO
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gufic Biosciences Limited, a public company from India, specializes in manufacturing and marketing active pharmaceutical ingredients and generic pharmaceuticals.
Gufic Biosciences major competitors are Orchid Pharma, Unichem Lab, Panacea Biotec, Indoco Remedies, Zota Health Care, Novartis, Guj. Themis Biosyn.
Market Cap of Gufic Biosciences is ₹3,502 Crs.
While the median market cap of its peers are ₹3,277 Crs.
Gufic Biosciences seems to be less financially stable compared to its competitors.
Altman Z score of Gufic Biosciences is 5.66 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jun Sep Dec | |||||||||||||||||
| Investor Presentation | May Aug | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Aug Sep | Mar Jun Dec | Mar Sep | ||||||||||||
| Conference Call | Mar | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Jun Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
